Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy L Weigel

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Molecular Endocrinology (Baltimore, Md.)|January 30, 2003
Identification of a transferable two-amino-acid motif (GT) present in the C-terminal tail of the human lutropin receptor that redirects internalized G protein-coupled receptors from a degradation to a recycling pathwayColette Galet, Le Min, Ramesh Narayanan, et al.
Steroids|October 2, 2007
PTHrP contributes to the anti-proliferative and integrin alpha6beta4-regulating effects of 1,25-dihydroxyvitamin D(3)Xiaoli Shen, Ramanjaneya V R Mula, Jing Li, et al.
The Journal of Urology|March 12, 2003
Regulation of Bcl-2 expression by dihydrotestosterone in hormone sensitive LNCaP-FGC prostate cancer cellsElizabeth M Bruckheimer, Kevin Spurgers, Nancy L Weigel, et al.
Endocrinology|December 10, 2020
Isoform-specific Activities of Androgen Receptor and its Splice Variants in Prostate Cancer CellsHarika Nagandla, Matthew J Robertson, Vasanta Putluri, et al.
Scientific Reports|January 15, 2021
Androgen receptor and its splice variant, AR-V7, differentially induce mRNA splicing in prostate cancer cellsManjul Rana, Jianrong Dong, Matthew J Robertson, et al.
Bone|June 23, 2004
Differential skeletal responses of hindlimb unloaded rats on a vitamin D-deficient diet to 1,25-dihydroxyvitamin D3 and its analog, seocalcitol (EB1089)Ramesh Narayanan, Matthew R Allen, Dana Gaddy, et al.
Molecular Cancer Therapeutics|July 9, 2009
EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cellsVandanajay Bhatia, Manjit K Saini, Xiaoli Shen, et al.
The Journal of Biological Chemistry|February 5, 2003
Mechanistic differences in the activation of estrogen receptor-alpha (ER alpha)- and ER beta-dependent gene expression by cAMP signaling pathway(s)Kevin M Coleman, Martin Dutertre, Abeer El-Gharbawy, et al.
Endocrinology|December 19, 2002
p53 Is required for 1,25-dihydroxyvitamin D3-induced G0 arrest but is not required for G1 accumulation or apoptosis of LNCaP prostate cancer cellsTara C Polek, LaMonica V Stewart, Elizabeth J Ryu, et al.
Journal of Molecular Endocrinology|June 9, 2007
Constitutively active FOXO1a and a DNA-binding domain mutant exhibit distinct co-regulatory functions to enhance progesterone receptor A activityMichael D Rudd, Ignacio Gonzalez-Robayna, Inmaculada Hernandez-Gonzalez, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Molecular Endocrinology (Baltimore, Md.)|January 30, 2003
Identification of a transferable two-amino-acid motif (GT) present in the C-terminal tail of the human lutropin receptor that redirects internalized G protein-coupled receptors from a degradation to a recycling pathwayColette Galet, Le Min, Ramesh Narayanan, et al.
Steroids|October 2, 2007
PTHrP contributes to the anti-proliferative and integrin alpha6beta4-regulating effects of 1,25-dihydroxyvitamin D(3)Xiaoli Shen, Ramanjaneya V R Mula, Jing Li, et al.
The Journal of Urology|March 12, 2003
Regulation of Bcl-2 expression by dihydrotestosterone in hormone sensitive LNCaP-FGC prostate cancer cellsElizabeth M Bruckheimer, Kevin Spurgers, Nancy L Weigel, et al.
Endocrinology|December 10, 2020
Isoform-specific Activities of Androgen Receptor and its Splice Variants in Prostate Cancer CellsHarika Nagandla, Matthew J Robertson, Vasanta Putluri, et al.
Scientific Reports|January 15, 2021
Androgen receptor and its splice variant, AR-V7, differentially induce mRNA splicing in prostate cancer cellsManjul Rana, Jianrong Dong, Matthew J Robertson, et al.
Bone|June 23, 2004
Differential skeletal responses of hindlimb unloaded rats on a vitamin D-deficient diet to 1,25-dihydroxyvitamin D3 and its analog, seocalcitol (EB1089)Ramesh Narayanan, Matthew R Allen, Dana Gaddy, et al.
Molecular Cancer Therapeutics|July 9, 2009
EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cellsVandanajay Bhatia, Manjit K Saini, Xiaoli Shen, et al.
The Journal of Biological Chemistry|February 5, 2003
Mechanistic differences in the activation of estrogen receptor-alpha (ER alpha)- and ER beta-dependent gene expression by cAMP signaling pathway(s)Kevin M Coleman, Martin Dutertre, Abeer El-Gharbawy, et al.
Endocrinology|December 19, 2002
p53 Is required for 1,25-dihydroxyvitamin D3-induced G0 arrest but is not required for G1 accumulation or apoptosis of LNCaP prostate cancer cellsTara C Polek, LaMonica V Stewart, Elizabeth J Ryu, et al.
Journal of Molecular Endocrinology|June 9, 2007
Constitutively active FOXO1a and a DNA-binding domain mutant exhibit distinct co-regulatory functions to enhance progesterone receptor A activityMichael D Rudd, Ignacio Gonzalez-Robayna, Inmaculada Hernandez-Gonzalez, et al.
Pageof 8